| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 6 | |
| #2 | EPO (European Patent Office) | 4 | |
| #3 | WIPO (World Intellectual Property Organization) | 3 | |
| #4 | Australia | 2 | |
| #5 | Canada | 2 | |
| #6 | China | 2 | |
| #7 | Hong Kong | 2 | |
| #8 | Republic of Korea | 2 | |
| #9 | Mexico | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Environmental technology | |
| #4 | Medical technology |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Peptides | |
| #3 | Medical preparations | |
| #4 | Climate change adaptation technologies | |
| #5 | Implantable devices |
| # | Name | Total Patents |
|---|---|---|
| #1 | Soares Christopher J | 24 |
| #2 | Lewis Diana Y | 2 |
| #3 | Jodka Carolyn M | 2 |
| #4 | Ghosh Soumitra S | 2 |
| #5 | Prickett Kathryn S | 2 |
| #6 | Hanley Michael R | 2 |
| #7 | Lin Qing | 2 |
| #8 | Parkes David Geoffrey | 1 |
| #9 | Mack Christine Marie | 1 |
| #10 | Parkes David G | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2018045083A1 | Use of cgrp receptor antagonists in neuroprotection and neurological disorders | |
| WO2015017455A1 | Cgrp agonist peptides | |
| CA2861392A1 | Peptide antagonists of the calcitonin cgrp family of peptide hormones and their use | |
| US5261923A | Method and apparatus for continuous circular capsulorehexis |